MedPath

Comparative study of centesimal and millesimal potency in treatment of allergic rhinitis

Phase 4
Conditions
Health Condition 1: J309- Allergic rhinitis, unspecified
Registration Number
CTRI/2022/05/042495
Lead Sponsor
Vinayaka Missions homoeopathic medical college and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

patients selected from age 10 to 60 and patients with clinical presentation of allergic rhinitis

Exclusion Criteria

cases with complications of allergic rhinitis and patients suffering from other systemic diseases and pregnant ladies will not be considered for the studies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath